Managing type 1 diabetes mellitus in pregnancy - From planning to breastfeeding

Nature Reviews Endocrinology

Volumn 8, Issue 11, 2012, Pages 659-667

  Ringholm, Lene ^a   Mathiesen, Elisabeth R ^a   Kelstrup, Louise ^a   Damm, Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FOLIC ACID; HEMOGLOBIN A1C; HYPOCHOLESTEROLEMIC AGENT; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; LABETALOL; LEVOTHYROXINE; METHYLDOPA; PROPYLTHIOURACIL; SHORT ACTING INSULIN; THIAMAZOLE;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; BREAST FEEDING; CARBOHYDRATE INTAKE; CONCEPTION; CONGENITAL MALFORMATION; CONTINUOUS INFUSION; CONTRACEPTION; COUNSELING; CREATININE BLOOD LEVEL; DENMARK; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FETUS DEATH; FETUS LUNG MATURATION; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LOW DRUG DOSE; MATERNAL DIABETES MELLITUS; MATERNAL HYPERTENSION; METABOLIC REGULATION; MICROALBUMINURIA; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCREENING; SELF MONITORING; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; THYROID FUNCTION;

ANIMALS; BREAST FEEDING; DIABETES MELLITUS, TYPE 1; DISEASE MANAGEMENT; FEMALE; FOLIC ACID; HUMANS; INFANT, NEWBORN; POSTNATAL CARE; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL CARE;

EID: 84867676486     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2012.154     Document Type: Article

References (119)

1. Boulot, P. et al. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 26, 2990-2993 (2003).
2. Casson, I. F. et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 315, 275-278 (1997). (Pubitemid 27326208)
3. Confidential Enquiry into Maternal and Child Health. Pregnancy in Women with Type 1 and Type 2 Diabetes in 2002-3, England, Wales and Northern Ireland (CEMACH, London, 2005).
4. Evers, I. M., de Valk, H. W. & Visser, G. H. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 328, 915 (2004).
5. Hawthorne, G. et al. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994. BMJ 315, 279-281 (1997). (Pubitemid 27326231)
6. Jensen, D. M. et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 27, 2819-2823 (2004). (Pubitemid 39565043)
7. Lapolla, A. et al. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. Acta Diabetol. 45, 61-66 (2008).
8. Macintosh, M. C. et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333, 177 (2006).
9. Penney, G. C., Mair, G. & Pearson, D. W. Outcomes of pregnancies in women with type 1 diabetes in Scotland: a national population-based study. BJOG 110, 315-318 (2003). (Pubitemid 36298919)
10. Platt, M. J. et al. St Vincent's Declaration 10 years on: outcomes of diabetic pregnancies. Diabet. Med. 19, 216-220 (2002). (Pubitemid 34429652)
11. Yang, J., Cummings, E. A., O'Connell, C. & Jangaard, K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet. Gynecol. 108, 644-650 (2006). (Pubitemid 44337107)
12. Lapolla, A. et al. A multicenter Italian study on pregnancy outcome in women with diabetes. Nutr. Metab. Cardiovasc. Dis. 18, 291-297 (2008). (Pubitemid 351707608)
13. Persson, M., Norman, M. & Hanson, U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: A large, population-based study. Diabetes Care 32, 2005-2009 (2009).
14. Boney, C. M., Verma, A., Tucker, R. & Vohr, B. R. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115, e290-e296 (2005). (Pubitemid 43373011)
15. Esakoff, T. F., Cheng, Y. W., Sparks, T. N. & Caughey, A. B. The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. Am. J. Obstet. Gynecol. 200, 672-674 (2009).
16. Schaefer-Graf, U. M. et al. Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes. Diabetes Care 28, 1745-1750 (2005). (Pubitemid 40923087)
17. Vohr, B. R., McGarvey, S. T. & Tucker, R. Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care 22, 1284-1291 (1999). (Pubitemid 29350238)
18. Hod, M. et al. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am. J. Obstet. Gynecol. 198, 186-187 (2008).
19. Hernandez, T. L., Friedman, J. E., van Pelt, R. E. & Barbour, L. A. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care 34, 1660-1668 (2011).
20. Damm, P., Mathiesen, E., Clausen, T. D. & Petersen, K. R. Contraception for women with diabetes mellitus. Metab. Syndr. Relat. Disord. 3, 244-249 (2005). (Pubitemid 41601242)
21. Varughese, G. I., Chowdhury, S. R., Warner, D. P. & Barton, D. M. Preconception care of women attending adult general diabetes clinics\-are we doing enough? Diabetes Res. Clin. Pract. 76, 142-145 (2007). (Pubitemid 46240358)
22. Mathiesen, E. R. & Damm, P. Pregnancy \-pharmacological problems. in Pharmacotherapy of Diabetes: New Developments. (Ed. Mogensen, C. E.) 249-255 (Springer, New York, 2009).
23. Temple, R. C., Aldridge, V. J. & Murphy, H. R. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 29, 1744-1749 (2006). (Pubitemid 44156624)
24. Tieu, J., Middleton, P. & Crowther, C. A. Preconception care for diabetic women for improving maternal and infant health. Cochrane Database of Systematic Reviews 2010 Issue 12. Art No.: CD007776 http://dx.doi.org/10.1002/ 14651858.CD007776.pub2
25. Murphy, H. R. et al. Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care 33, 2514-2520 (2010).
26. Inkster, M. E. et al. Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnancy Childbirth, 6 30 (2006).
27. International Diabetes Federation. Global Guidelines on Pregnancy and Diabetes [online] http://www.idf.org/webdata/docs/Pregnancy- EN-RTP.pdf (2009).
28. Guideline Development Group. Management of diabetes from preconception to the postnatal period: summary of NICE guidance. BMJ 336, 714-717 (2008).
29. National Institute of Health and Clinical Excellence. Diabetes in pregnancy: management of diabetes and its complications from preconception to the post-natal period [online] www.nice.org.uk/CG063 (2008).
30. Nielsen, L. R. et al. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 31, 9-14 (2008).
31. Wilson, R. D. et al. The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J. Obstet. Gynaecol. Can. 25, 959-973 (2003).
32. Capel, I. & Corcoy, R. What dose of folic acid should be used for pregnant diabetic women? Diabetes Care 30, e63 (2007). (Pubitemid 47036389)
33. Bar, J., et al. Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy. J. Pediatr. Endocrinol. Metab. 12, 659-665 (1999). (Pubitemid 29422062)
34. Cooper, W. O. et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N. Engl. J. Med. 354, 2443-2451 (2006). (Pubitemid 43855047)
35. Porta, M. et al. Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled Diabetic Retinopathy Candesartan Trials. Diabetologia 54 1298-1303 (2011).
36. Li, D. K., Yang, C., Andrade, S., Tavares, V. & Ferber, J. R. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 343, d5931 (2011).
37. Shotan, A., Widerhorn, J., Hurst, A. & Elkayam, U. Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am. J. Med. 96, 451-456 (1994). (Pubitemid 24156732)
38. Tabacova, S., Little, R., Tsong, Y., Vega, A. & Kimmel, C.A. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol. Drug. Saf. 12, 633-646 (2003). (Pubitemid 38028777)
39. Sibai, B. M. Chronic hypertension in pregnancy. Obstet. Gynecol. 100, 369-377 (2002). (Pubitemid 34874806)
40. Nielsen, L. R., Muller, C., Damm, P. & Mathiesen, E. R. Reduced prevalence of early preterm delivery in women with Type 1 diabetes and microalbuminuria\-possible effect of early antihypertensive treatment during pregnancy. Diabet. Med. 23, 426-431 (2006).
41. Nielsen, L. R., Damm, P. & Mathiesen, E. R. Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 32, 38-44 (2009).
42. Vestgaard, M. et al. Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetes. Diabet. Med. 27, 431-435 (2010).
43. Vestgaard, M., Nielsen, L. R., Rasmussen, A. K., Damm, P. & Mathiesen, E. R. Thyroid peroxidase antibodies in pregnant women with type 1 diabetes: impact on thyroid function, metabolic control and pregnancy outcome. Acta Obstet. Gynecol. Scand. 87, 1336-1342 (2008).
44. Haddow, J. E. et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 341, 549-555 (1999). (Pubitemid 29384162)
45. Abalovich, M. et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 92, S1-S47 (2007). (Pubitemid 47236338)
46. Kitzmiller, J. L. et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care 31, 1060-1079 (2008).
47. Jovanovic, L. & Inturissi, M. Assessment of glycemic control. In Managing Preexisting Diabetes Mellitus for Pregnancy. (Ed. Kitzmiller, J. L.) 9-15 (American Diabetes Association, 2008).
48. Kerssen A, de Valk, H. W. & Visser, G. H. Do HbA1c levels and the self-monitoring of blood glucose levels adequately reflect glycaemic control during pregnancy in women with type 1 diabetes mellitus? Diabetologia 49, 25-28 (2006). (Pubitemid 43151609)
49. Garcia-Patterson, A. et al. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia 53, 446-451 (2010).
50. Mathiesen, E. R. et al. Insulin dose during glucocorticoid treatment for fetal lung maturation in diabetic pregnancy: test of an algorithm. Acta Obstet. Gynecol. Scand. 81, 835-839 (2002). (Pubitemid 35026059)
51. Murphy, H. R. et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 337, a1680 (2008).
52. Worm, D., Nielsen, L. R., Mathiesen, E. R. & Norgaard, K. Continuous glucose monitoring system with an alarm: a tool to reduce hypoglycemic episodes in pregnancy with diabetes. Diabetes Care 29, 2759-2760 (2006). (Pubitemid 44912218)
53. 1c in pregnant women: data from an Italian multicenter study. Clin. Chem. 52, 1138-1143 (2006). (Pubitemid 43794427)
54. 1c levels are significantly lower in early and late pregnancy. Diabetes Care 27, 1200-1201 (2004). (Pubitemid 38579790)
55. Mills, J. L. et al. Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the diabetes in early pregnancy study. Metabolism 47, 1140-1144 (1998). (Pubitemid 28428021)
56. Lurie, S. & Danon, D. Life span of erythrocytes in late pregnancy. Obstet. Gynecol. 80, 123-126 (1992).
57. Kerssen, A., de Valk, H. W. & Visser, G. H. Forty-eight-hour first-trimester glucose profiles in women with type 1 diabetes mellitus: a report of three cases of congenital malformation. Prenat. Diagn. 26, 123-127 (2006). (Pubitemid 43287094)
58. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary. (London, 2006).
59. FDA NovoLog label [online] http://www.accessdata.fda.gov/drugsatfda-docs/ label/2008/020986s047lbl.pdf (2008).
60. FDA Humalog label [online] http://www.accessdata.fda.gov/drugsatfda-docs/ label/2011/020563s098s105lbl.pdf (2011).
61. EMA Novolog label [online] http://www.ema. europa.eu/docs/en-GB/document- library/EPAR-Product-Information/human/000258/WC500030372.pdf (2009).
62. EMA Humalog label. http://www.ema.europa. eu/docs/en-GB/document-library/ EPAR- Product-Information/human/000088/WC500050332.pdf (2006).
63. Mathiesen, E. R. et al. Maternal glycemic control and hypoglycemia in Type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 30, 771-776 (2007). (Pubitemid 46556565)
64. Mathiesen, E. R. et al. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. http://dx.doi.org/10.2337/dc11-2264
65. FDA detemir label [online] http://www.accessdata.fda.gov/drugsatfda-docs/ label/2012/021536s037lbl.pdf (2005).
66. Gallen, I. W., Jaap, A., Roland, J. M. & Chirayath, H. H. Survey of glargine use in 115 pregnant women with Type 1 diabetes. Diabet. Med. 25, 165-169 (2008). (Pubitemid 351293402)
67. Lapolla, A. et al. Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women. Diabet. Med. 26, 1181-1182 (2009).
68. Poyhonen-Alho, M., Ronnemaa, T., Saltevo, J., Ekblad, U. & Kaaja, R. J. Use of insulin glargine during pregnancy. Acta Obstet. Gynecol. Scand. 86, 1171-1174 (2007). (Pubitemid 47463728)
69. Gabbe, S. G., Carpenter, L. B. & Garrison, E. A. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy. Clin. Obstet. Gynecol. 50, 1014-1024 (2007). (Pubitemid 350059299)
70. McCance, D. & Holmes, V. A. Insulin regimens in pregnancy in A practical Manual of Diabetes in Pregnancy 99-109 (Blackwell Publishing Ltd, Oxford, UK, 2010).
71. Workgroup on Hypoglycaemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28, 1245-1249 (2005).
72. Rosenn, B. M., Miodovnik, M., Holcberg, G., Khoury, J. C. & Siddiqi, T. A. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet. Gynecol. 85, 417-422 (1995).
73. Kimmerle, R., Heinemann, L., Delecki, A. & Berger, M. Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care 15, 1034-1037 (1992).
74. Leinonen, P. J., Hiilesmaa, V. K., Kaaja, R. J. & Teramo, K. A. Maternal mortality in type 1 diabetes. Diabetes Care 24, 1501-1502 (2001).
75. Evers, I. M. et al. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. Diabetes Care 25, 554-559 (2002). (Pubitemid 41103352)
76. Robertson, H., Pearson, D. W. & Gold, A. E. Severe hypoglycaemia during pregnancy in women with Type 1 diabetes is common and planning pregnancy does not decrease the risk. Diabet. Med. 26, 824-826 (2009).
77. Buchanan, T. A., Schemmer, J. K. & Freinkel, N. Embryotoxic effects of brief maternal insulin-hypoglycemia during organogenesis in the rat. J. Clin. Invest. 78, 643-649 (1986). (Pubitemid 16024797)
78. Kawaguchi, M., Tanigawa, K., Tanaka, O. & Kato, Y. Embryonic growth impaired by maternal hypoglycemia during early organogenesis in normal and diabetic rats. Acta Diabetol. 31, 141-146 (1994). (Pubitemid 24306995)
79. Smoak, I. W. & Sadler, T. W. Embryopathic effects of short-term exposure to hypoglycemia in mouse embryos in vitro. Am. J. Obstet. Gynecol. 163, 619-624 (1990). (Pubitemid 20287647)
80. [No authors listed] Pregnancy outcomes in the Diabetes Control and Complications Trial. Am. J. Obstet. Gynecol. 174, 1343-1353 (1996).
81. Ringholm, L., Pedersen-Bjergaard, U., Thorsteinsson, B., Damm, P. & Mathiesen, E. R. Hypoglycaemia during pregnancy in women with Type 1 diabetes. Diabet. Med. 29, 558-566 (2012).
82. Garcia-Dominguez, M. et al. Use of insulin lispro during pregnancy in women with pregestational diabetes mellitus. Med. Clin. (Barc.) 137, 581-586 (2011).
83. Heller, S. R. et al. Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes. Diabet. Med. 21, 769-775 (2004). (Pubitemid 38916224)
84. Imbergamo, M. P. et al. Use of glargine in pregnant women with type 1 diabetes mellitus: a case- control study. Clin. Ther. 30, 1476-1484 (2008).
85. Secher, A. L. et al. Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes. Diabet. Med. 29, 272-277 (2012).
86. Hegaard, H. K., Pedersen, B. K., Nielsen, B. B. & Damm, P. Leisure time physical activity during pregnancy and impact on gestational diabetes mellitus, pre-eclampsia, preterm delivery and birth weight: a review. Acta Obstet. Gynecol. Scand. 86, 1290-1296 (2007). (Pubitemid 350034542)
87. Jovanovic, L. G. Using meal-based self-monitoring of blood glucose as a tool to improve outcomes in pregnancy complicated by diabetes. Endocr. Pract. 14, 239-247 (2008).
88. Leontos, C. Implementing the American Diabetes Association's nutrition recommendations. J. Am. Osteopath. Assoc. 103, S17-S20 (2003).
89. Hanson, U. & Persson, B. Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden. Acta Obstet. Gynecol. Scand. 77, 620-624 (1998). (Pubitemid 28416507)
90. Holmes, V. A. et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care 34, 1683-1688 (2011).
91. Siddiqi, T., Rosenn, B., Mimouni, F., Khoury, J. & Miodovnik, M. Hypertension during pregnancy in insulin-dependent diabetic women. Obstet. Gynecol. 77, 514-519 (1991).
92. Bartha, J. L., Romero-Carmona, R., Torrejon-Cardoso, R., Comino-Delgado, R. Insulin, insulinlike growth factor-1, and insulin resistance in women with pregnancy-induced hypertension. Am. J. Obstet. Gynecol. 187, 735-740 (2002).
93. Seely, E. W. & Solomon, C. G. Insulin resistance and its potential role in pregnancy-induced hypertension. J. Clin. Endocrinol. Metab. 88, 2393-2398 (2003). (Pubitemid 36724402)
94. Sierra-Laguado, J. et al. Determination of insulin resistance using the homeostatic model assessment (HOMA) and its relation with the risk of developing pregnancy-induced hypertension. Am. J. Hypertens. 20, 437-442 (2007). (Pubitemid 46441759)
95. Solomon, C. G. & Seely, E. W. Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome? Hypertension 37, 232-239 (2001). (Pubitemid 32199080)
96. Ferriss, J. B. The causes of raised blood pressure in insulin-dependent and non-insulin-dependent diabetes. J. Hum. Hypertens. 5, 245-254 (1991).
97. Leguizamon, G. F., Zeff, N. P., Fernandez A: Hypertension and the pregnancy complicated by diabetes. Curr. Diab. Rep. 6, 297-304 (2006). (Pubitemid 44322702)
98. Ekbom, P. et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 24, 1739-1744 (2001). (Pubitemid 33716475)
99. Rossing, K. et al. Pregnancy and progression of diabetic nephropathy. Diabetologia 45, 36-41 (2002). (Pubitemid 34118540)
100. Sibai, B. M. Diabetic nephropathy in pregnancy. in A Practical Manual of Diabetes in Pregnancy. 153-156 (Blackwell Publishing, Oxford, 2008).
101. [No authors listed] Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial. The Kroc Collaborative Study Group. N. Engl. J. Med. 311, 365-372 (1984).
102. [No authors listed] The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329, 977-986 (1993).
103. Lawson, P. M. et al. Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy. Br. J. Ophthalmol. 66, 762-766 (1982). (Pubitemid 13254877)
104. Chew, E. Y. et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care 18, 631-637 (1995).
105. Okosieme, O. E., Marx, H. & Lazarus, J. H. Medical management of thyroid dysfunction in pregnancy and the postpartum. Expert Opin. Pharmacother. 9, 2281-2293 (2008).
106. Mathiesen, E. R., Ringholm, L. & Damm, P. Stillbirth in diabetic pregnancies. Best Pract. Res. Clin. Obstet. Gynaecol. 25, 105-111 (2011).
107. Conway, D. L. & Catalano, P. M. Obstetrical management of women with preexisting diabetes mellitus. In Managing Preexisting Diabetes and Pregnancy. American Diabetes Association Technical Reviews and Consensus Recommendations for Care. (Ed. Kitzmiller, J. L.) 561-601 (American Diabetes Association, 2008).
108. Jovanovic, L. Glucose and insulin requirements during labor and delivery: the case for normoglycemia in pregnancies complicated by diabetes. Endocr. Pract. 10, (Suppl. 2) 40-45 (2004).
109. Stage, E., Mathiesen, E. R., Emmersen, P. B., Greisen, G. & Damm, P. Diabetic mothers and their newborn infants\-rooming-in and neonatal morbidity. Acta Paediatr. 99, 997-999 (2010).
110. Inturris, M. Benefits and concerns of breastfeeding in women with diabetes. In Managing Preexisting Diabetes and Pregnancy. (Ed. Kitzmiller, J. L.) 697-727 (American Diabetes Association, 2008).
111. Stage, E., Norgard, H., Damm, P. & Mathiesen, E. Long-term breast-feeding in women with type 1 diabetes. Diabetes Care 29, 771-774 (2006). (Pubitemid 44115292)
112. [No authors listed] Preparing pregnant women with diabetes for special breast-feeding challenges. J. Am. Diet. Assoc. 98, 648 (1998).
113. Hummel, S. et al. Breastfeeding habits in families with Type 1 diabetes. Diabet. Med. 24, 671-676 (2007). (Pubitemid 46808871)
114. Sorkio, S. et al. Breastfeeding patterns of mothers with type 1 diabetes: results from an infant feeding trial. Diabetes Metab. Res. Rev. 26, 206-211 (2010).
115. Riviello, C., Mello, G. & Jovanovic, L. G. Breastfeeding and the basal insulin requirement in type 1 diabetic women. Endocr. Pract. 15, 187-193 (2009).
116. Beardmore, K. S., Morris, J. M. & Gallery, E. D. Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens. Pregnancy 21, 85-95 (2002). (Pubitemid 34437748)
117. Shannon, M. E., Malecha, S. E. & Cha, A. J. Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) and lactation: an update. J. Hum. Lact. 16, 152-155 (2000).
118. Shannon, M. E., Malecha, S. E. & Cha, A. J. Beta blockers and lactation: an update. J. Hum. Lact. 16, 240-245 (2000).
119. [No authors listed] American Academy of Pediatrics Committee on Drugs: The transfer of drugs and other chemicals into human milk. Pediatrics 93, 137-150 (1994).